| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |